Postdural Puncture Headache
Conditions
Keywords
intravenous dexamethazone, intrathecal dexamethazzone
Brief summary
This study will be conducted at Ain Shams University Hospital in Operating Theatre after ethical committe approval number (MS 32/ 2020). It is a prospective randomized controlled study will be done on patients undergoing lower abdominal and lower limb surgeries under spinal anethesia,Eligible patients will be randomized by computer system to one of two groups, either intravenous dexamethazzoe 8 mg with intrathecal heavy bupivacaine 0.5% or intrathecal 4mg dexamethazone with intrathecal heavy bupivacaine 0.5%. .
Detailed description
Patients will be randomly divided into two equal groups: Group 1: patients receive intrathecal 3 ml bupivacaine 0. 5% +1 ml normal saline + intravenous 8 mg dexamethazone in 10 ml saline. Group 2: patients receive intrathecal 3 ml bupivacaine 0. 5% + 4 mg (1 ml) dexamethazone + intravenous 10 ml normal saline. Upon patients' arrival into the operating room, peripheral oxygen saturation (SPO2), ECG, pulse rate (PR), and systolic and diastolic blood pressures will be monitored one of the researchers and recorded every 5 minutes till the end of surgery. In a sitting position and with antiseptic techniques, 25 G Quincke needle was inserted intrathecally at L3-L4 or L4-L5 interspace through midline approach. The study drugs were given by an anesthesiologist not not aware of the type of medications injected. Subsequently, the patients were put in the supine position, and given oxygen 3 L/minutes by nasal prongs.
Interventions
Evaluation of intravenous dexamethazone in prevention of postdural puncture headache
Evaluation of intrathecal dexamethazone in prevention of postdural puncture headache
Sponsors
Study design
Masking description
double (participant and outcome assessor)
Intervention model description
Parallel assignment
Eligibility
Inclusion criteria
* Patients ASA I or II undergoing lower limb surgeries under spinal anesthesia * Patients ASAI or II undergoing lower abdominal surgeries under spinal anesthesia.
Exclusion criteria
* Emergency surgeries. * Patients with uncompensated heart diseases. * Patients with coagulopathy. * Presence of infection at site of injection of spinal anesthesia.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevention of postdural puncture headache | 48 hours after spinal anesthesia | prevention of postdural puncture headache after spinal anesthesia in the first 48 hours postoperatively |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Duration of sensory block | 4 hours from injection of drug in subarachnoid space. | Duration of sensory block after spinal anesthesia from injection of drug till regain of sensation at level of T10 |
Countries
Egypt